The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Latest on Eosinophilic Granulomatosis with Polyangiitis

The Latest on Eosinophilic Granulomatosis with Polyangiitis

July 19, 2018 • By Paul A. Monach, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Rawpixel.com / shutterstock.com

Rawpixel.com / shutterstock.com

The past five years have been busier than usual for the Churg-Strauss syndrome. It was renamed eosinophilic granulomatosis with polyangiitis (EGPA).1 Longitudinal cohorts totaling 484 patients—approximately as many as all previous series combined—were described.2,3 A proposal was advanced to remove and rename a subset in which vasculitis may not be present.4 And shortly after the production of consensus guidelines for management, the portion of the evidence base comprising relatively large, randomized trials more than doubled.5

You Might Also Like
  • Promising Treatment for Eosinophilic Granulomatosis with Polyangiitis
  • Granulomatosis with Polyangiitis: A Case Review
  • Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis
Explore This Issue
July 2018
Also By This Author
  • Maintenance of Remission in ANCA-Associated Vasculitis

The Long & the Short of It

EGPA is a good name—and manageable once shortened to four letters. It describes the definitive pathology well. Just as with granulomatosis with polyangiitis (GPA, Wegener’s), EGPA does not feature granulomatous vasculitis, nor are eosinophils essential to the process of vasculitis. Rather, the eosinophilic granulomas are nearby, hence “with.” GPA is no longer the only rheumatic disease with a “with” in the name.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Churg-Strauss is an easier name to remember, but it doesn’t help physicians remember the clinical features, nor does it help patients educate their family and friends. What isn’t captured in the new name is that many features of the disease are characterized by eosinophilic inflammation into tissues, without necessarily being accompanied by vasculitis or necrotizing granulomatous inflammation. As far as can be determined, the pathology of nasal inflammation is indistinguishable from that of isolated nasal polyps; the parenchymal lung pathology is often the same as isolated eosinophilic pneumonia; and the eosinophilic myocarditis is indistinguishable from that seen in hypereosinophilic syndromes.

Sometimes 100 Is a Lot

* Severe renal disease was defined by Comarmond as meeting Five Factor Score criteria for reduced renal function or proteinuria, and by Durel as having evidence for glomerulonephritis.

(click for larger image) Table 1: Manifestations of EGPA in 2 Recent Observational Cohort Studies
* Severe renal disease was defined by Comarmond as meeting Five Factor Score criteria for reduced renal function or proteinuria, and by Durel as having evidence for glomerulonephritis.

The series by Comarmond and the French Vasculitis Study Group (FVSG), and by Durel, provide useful details on clinical manifestations. A summary of organ system involvement is shown in Table 1, but readers are advised to look in the papers at the diversity of manifestations within a given organ system. For example, in the FVSG study, cutaneous manifestations (present in 40% of patients at diagnosis) are subdivided into purpura (23%), urticarial lesions (10%), subcutaneous nodules (10%), livedo reticularis (4%) and necrotic/gangrenous lesions (4%). Kidney involvement was surprisingly high (22–26%), but severe involvement was much less common (4–6%).2,3 Consistent with previous studies, 31–43% of patients were ANCA positive, and this was the group at risk for GN.3 Also consistent with previous studies, ANCA-positive patients were more likely to have peripheral neuropathy and ANCA-negative patients were more likely to have cardiomyopathy, although differences were not nearly as large as with GN.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Vasculitis Tagged With: EGPA, Eosinophilic Granulomatosis, PolyangiitisIssue: July 2018

You Might Also Like:
  • Promising Treatment for Eosinophilic Granulomatosis with Polyangiitis
  • Granulomatosis with Polyangiitis: A Case Review
  • Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis
  • The Classification & Diagnosis of Granulomatosis with Polyangiitis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.